Top Tools for Measuring AD in Clinical Practice Recommended
Consensus was reached during an in-person meeting attended by 34 individuals with diverse backgrounds.
Source: medscape.com
Ericl Simpson News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Ericl Simpson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Ericl Simpson Today - Breaking & Trending Today
Ruxolitinib Cream Improves Itch, Sleep, Skin Pain in Children with Atopic Dermatitis
A secondary analysis from TRuE-AD3 shows ruxolitinib cream significantly benefits pediatric atopic dermatitis patient-reported outcomes.
Source: hcplive.com
Dupilumab Improves AD Affecting the Hands, Feet
Dupilumab monotherapy was an effective and safe systemic treatment for patients with moderate to severe hand and foot atopic dermatitis.
Source: medscape.com
Improvements in Atopic Dermatitis from Ruxolitinib Treatment Observed Past Vehicle-Controlled Period
This new post-hoc analysis of ruxolitinib cream for those with eczema indicates that continued treatment past 8 weeks may lead to further benefit for those with the skin disease.
Source: hcplive.com
ASLAN Pharmaceuticals Presents New Data From Phase 2b Study of Eblasakimab in Atopic Dermatitis ...
Data presented during the late-breaker oral presentation of the TREK-AD study demonstrate e blasakimab’s potential as the first biologic in moderate-to-severe atopic dermatitis to demonstrate a competitive efficacy profile with
Source: eagletribune.com